HER2+ Early Breast Cancer: Treatment Optimization and Review of Standard-of-Care Neoadjuvant Regimens

Heather McArthur, MD, and Debu Tripathy, MD, lead a discussion on risk stratification and optimizing treatment for HER2+ early breast cancer (eBC), followed by a review of standard-of-care systemic therapy regimens in the preoperative/neoadjuvant setting.

Related Keywords

Heather Mcarthur , ,Breast Cancer ,Recent Data Updates ,Key Advances ,Early Breast Cancer ,Treatment Optimization ,Standard Of Care Neoadjuvant ,Debu Tripathy ,